AU2001265841A1 - Use of potassium channel openers for the treatment of insulitis - Google Patents

Use of potassium channel openers for the treatment of insulitis

Info

Publication number
AU2001265841A1
AU2001265841A1 AU2001265841A AU6584101A AU2001265841A1 AU 2001265841 A1 AU2001265841 A1 AU 2001265841A1 AU 2001265841 A AU2001265841 A AU 2001265841A AU 6584101 A AU6584101 A AU 6584101A AU 2001265841 A1 AU2001265841 A1 AU 2001265841A1
Authority
AU
Australia
Prior art keywords
insulitis
treatment
potassium channel
channel openers
openers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001265841A
Inventor
Elisabeth Bjork
John Bondo Hansen
Anders Karlsson
Mikael Kullin
Zhanchun Li
Jesper Svendstorp Lund
Birgitte Michelsen
Stellan Sandler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2001265841A1 publication Critical patent/AU2001265841A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001265841A 2000-06-26 2001-06-25 Use of potassium channel openers for the treatment of insulitis Abandoned AU2001265841A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200000988 2000-06-26
DKPA200000988 2000-06-26
PCT/DK2001/000444 WO2002000665A1 (en) 2000-06-26 2001-06-25 Use of potassium channel openers for the treatment of insulitis

Publications (1)

Publication Number Publication Date
AU2001265841A1 true AU2001265841A1 (en) 2002-01-08

Family

ID=8159578

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001265841A Abandoned AU2001265841A1 (en) 2000-06-26 2001-06-25 Use of potassium channel openers for the treatment of insulitis

Country Status (2)

Country Link
AU (1) AU2001265841A1 (en)
WO (1) WO2002000665A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002365289A1 (en) * 2001-11-30 2003-06-10 Novo Nordisk A/S Use of selective potassium channel openers
AU2002342600A1 (en) * 2001-11-30 2003-06-10 Novo Nordisk A/S Use of selective potassium channel openers
WO2004005299A1 (en) * 2002-07-04 2004-01-15 Novo Nordisk A/S Polymorphic forms of a 4h-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivative
NL2022291B1 (en) * 2018-12-21 2020-07-21 Academisch Ziekenhuis Leiden Compound for Use in Treatment and Prevention of Type I Diabetes
WO2020130836A1 (en) * 2018-12-21 2020-06-25 ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) Compound for use in treatment and prevention of type i diabetes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1368948A (en) * 1970-11-11 1974-10-02 Manuf Prod Pharma Pyridine derivatives
FR2703051B1 (en) * 1993-03-26 1995-04-28 Adir New pyridothiadiazines, processes for their preparation, and pharmaceutical compositions containing them.
US6225310B1 (en) * 1996-01-17 2001-05-01 Novo Nordisk A/S Fused 1,2,4-thiadiazine derivatives, their preparation and use
AU727775B2 (en) * 1996-01-17 2000-12-21 Novo Nordisk A/S Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
DK1140945T3 (en) * 1998-12-18 2003-09-15 Novo Nordisk As Condensed 1,2,4-thiadiazine derivatives, their preparation and use

Also Published As

Publication number Publication date
WO2002000665A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
AU5557700A (en) New uses for potassium channel openers
GB2390091B (en) Bisarylamines as potassium channel openers
AU2002223827A1 (en) Well treatment
AU2001261262A1 (en) Glaucoma treatment device
AU2001275511A1 (en) Guide for medical devices
AUPQ893200A0 (en) Medical residue treatment
AU2002327209A1 (en) Topical composition for treating pain
AU2002323666A1 (en) Diaper tab grips
AU2000276362A1 (en) Composition for the treatment of diabetes
AU2001265839A1 (en) Use of potassium channel agonists for the treatment of cancer
AU2002324201A1 (en) Waste treatment
AU2001293891A1 (en) New combination for the treatment of asthma
EP1421936A4 (en) Potassium channel opener
AU2002319286A1 (en) Skin treatment
AU2001265841A1 (en) Use of potassium channel openers for the treatment of insulitis
WO2002010164A3 (en) Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
AU2002225327A1 (en) Apparatus for aesthetic treatment
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
AU2002338572A1 (en) 66784, a novel human potassium channel and uses therefor
AU2002304883A1 (en) Device for the treatment of tumours
AU2001261324A1 (en) Psoriasis treatment
AU2001282349A1 (en) Fluid treatment
AU2001293816A1 (en) Tanning device, especially full body tanning device
AU2002365289A1 (en) Use of selective potassium channel openers
AUPQ790900A0 (en) Treatment for scrubber effulent